“Transmasculine Gender Affirming Care In The Primary Care Setting” & “Reducing The Burden Of Chronic Graft-Versus-Host Diseases (CGVHD)” (Hybrid Event)

Samantha Gonzalez, MD

Assistant Professor of Clinical Medicine

University of Miami Miller School of Medicine

Dr. Samantha Gonzalez completed her undergraduate studies at the University of Miami and went on to attend Ponce School of Medicine where she attained her medical degree. She rejoined the University of Miami to complete a combined Med-Peds residency at UMiami/Jackson Memorial Hospital, where she later served as the Ambulatory Chief Resident for the Internal Medicine residency program. With an interest in both primary care and medical education, she joined Holy Cross Hospital in Fort Lauderdale where she served as Associate Program Director for their University of Miami Internal Medicine Residency Program while practicing primary care and working closely with the LGBTQ+ community in her Wilton Manors practice.

She rejoined the University in 2022 as a Primary Care Physician at UHealth Fisher Island, and currently serves as an Ambulatory Associate Program Director for the Internal Medicine residency program. In addition to her roles in primary care and medical education, she is a Senior Advisor for Child Health for the Global Institute and is a volunteer medical director for the student-run DOCS Rapid Access Wellness clinic, which focuses on providing free gender-affirming hormonal care in the greater Miami-Dade community.

Trent Wang, DO

Associate Professor of Clinical Medicine

University of Miami Miller School of Medicine

Dr. Trent Wang is an Associate Professor of Clinical Medicine within the Division of Transplantation and Cellular Therapy. Since joining Sylvester Comprehensive Cancer Center, his clinical focus has been treating patients with hematologic cancers who require allogeneic hematopoietic stem cell transplantation and other cellular therapies. Dr. Wang’s research focuses on complications of allogeneic hematopoietic stem cell transplantation, including conducting interventional, behavioral and retrospective studies of graft-versus-host disease, infectious transplant complications, and transplant survivorship. Dr. Wang also studies the outcomes of immune effector cell therapies such as CAR-T cells for various oncologic indications.

Join Meeting!

Objectives

Dr. Gonzalez’s Presentation

• Describe known barriers to medical care for transgender and nonbinary patients.
• Initiate transmasculine medical hormonal therapy with appropriate surveillance.
• Review special considerations in the care of transmasculine patients including non-medical strategies for gender affirmation.
• Assess cancer screening recommendations for transmasculine patients.

Dr. Wang’s Presentation

• Review the progress of CGVHD Therapeutic interventions.
• Identify areas of need in CGVHD survivors.
• Compare behavioral health studies for CGVHD survivors.

Faculty Disclosures

Dr. Gonzalez has indicated that she has no relevant financial relationships with commercial interests.

Dr. Wang has indicated that he has the following relevant financial relationships with commercial interests:

• Consultant & Grant or Research Support – Sanofi S.A.
• Consultant – Gilead Sciences, Inc.

Planning Committee Disclosure

Dr. Deshpande has indicated that he has no relevant financial relationships with commercial interests.
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:

• Consultant – Prizm LLC
  

Target Audience

Primary care physicians.

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”